- Home
- ACLX vs RDN Comparison
ACLX vs RDN Comparison
Compare ACLX & RDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACLX | RDN |
|---|---|---|
| Founded | 2015 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 5.0B |
| IPO Year | 2022 | 1992 |
Fundamental Metrics
Financial Performance| Metric | ACLX | RDN |
|---|---|---|
| Price | $66.18 | $36.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 4 |
| Target Price | ★ $115.71 | $38.75 |
| AVG Volume (30 Days) | ★ 1.4M | 928.1K |
| Earning Date | 11-05-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.78% |
| EPS Growth | N/A | ★ 3.60 |
| EPS | N/A | ★ 4.00 |
| Revenue | $35,898,000.00 | ★ $1,273,225,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $293.08 | $2.43 |
| P/E Ratio | ★ N/A | $9.19 |
| Revenue Growth | N/A | ★ 2.49 |
| 52 Week Low | $47.86 | $29.32 |
| 52 Week High | $94.07 | $38.84 |
Technical Indicators
Market Signals| Indicator | ACLX | RDN |
|---|---|---|
| Relative Strength Index (RSI) | 36.03 | 63.92 |
| Support Level | $63.48 | $36.42 |
| Resistance Level | $66.30 | $36.94 |
| Average True Range (ATR) | 3.54 | 0.61 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 15.49 | 83.19 |
Price Performance
Historical ComparisonAbout ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.